BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1655867)

  • 1. Pharmacokinetics and toxicity of intraarterial adriamycin for hepatocellular carcinoma: effect of coadministration of lipiodol.
    Johnson PJ; Kalayci C; Dobbs N; Raby N; Metivier EM; Summers L; Harper P; Williams R
    J Hepatol; 1991 Jul; 13(1):120-7. PubMed ID: 1655867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraarterial adriamycin and lipiodol for inoperable hepatocellular carcinoma: a comparison with intravenous adriamycin.
    Kalayci C; Johnson PJ; Raby N; Metivier EM; Williams R
    J Hepatol; 1990 Nov; 11(3):349-53. PubMed ID: 1705275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacy and toxicity of standard dose adriamycin in hyperbilirubinaemic patients with hepatocellular carcinoma: relation to liver tests and pharmacokinetic parameters.
    Johnson PJ; Dobbs N; Kalayci C; Aldous MC; Harper P; Metivier EM; Williams R
    Br J Cancer; 1992 May; 65(5):751-5. PubMed ID: 1316777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of arterial injection of lipiodol-adriamycin emulsion on hepatocellular carcinoma].
    Sonoyama T; Hironaka T; Inaba S; Tsukamoto K; Nonaka M; Makino H; Kohnosu H; Oka T
    Nihon Gan Chiryo Gakkai Shi; 1986 May; 21(4):773-9. PubMed ID: 3020138
    [No Abstract]   [Full Text] [Related]  

  • 5. Adriamycin-lipiodol suspension for i.a. chemotherapy of hepatocellular carcinoma.
    Katagiri Y; Mabuchi K; Itakura T; Naora K; Iwamoto K; Nozu Y; Hirai S; Ikeda N; Kawai T
    Cancer Chemother Pharmacol; 1989; 23(4):238-42. PubMed ID: 2538250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Transcatheter oily chemoemobolization of hepatocellular carcinoma using adriamycin, lipiodol and gelfoam: pharmacokinetics of adriamycin].
    Nakamura H; Hashimoto T; Taguchi T; Inoue K; Oi H
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):623-5. PubMed ID: 3006598
    [No Abstract]   [Full Text] [Related]  

  • 7. A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead.
    Poon RT; Tso WK; Pang RW; Ng KK; Woo R; Tai KS; Fan ST
    Clin Gastroenterol Hepatol; 2007 Sep; 5(9):1100-8. PubMed ID: 17627902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraaterial hepatic infusion and intravenous adriamycin for treatment of hepatocellular carcinoma: a clinical and pharmacology report.
    Bern MM; McDermott W; Cady B; Oberfield RA; Trey C; Clouse ME; Tullis JL; Parker LM
    Cancer; 1978 Aug; 42(2):399-405. PubMed ID: 209882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcatheter oily chemoembolization with high doses of adriamycin in the treatment of large hepatocellular carcinoma (10 cm or more in diameter).
    Nakamura H; Hashimoto T; Inoue Y; Inoue K; Akaji H; Sawada S
    Radiat Med; 1990; 8(5):188-90. PubMed ID: 1963695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pulmonary complication following intra-arterial infusion of lipiodol-adriamycin emulsion for hepatocellular carcinoma, report of a case].
    Samejima M; Tamura S; Kodama T; Yuuki Y; Takasaki J; Sekiva R; Koga Y; Watanabe K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Jan; 50(1):24-8. PubMed ID: 2158647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disposition of epirubicin after intraarterial administration in Lipiodol to patients with hepatocellular carcinoma.
    Dodds HM; Walpole ET; Rivory LP; Strong RW; Pond SM
    Ther Drug Monit; 1996 Oct; 18(5):537-43. PubMed ID: 8885116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative randomized trial of intermittent intrahepatic arterial carboplatin- versus doxorubicin-lipiodol emulsion in advanced hepatocellular carcinoma (stage IV).
    Homma H; Mezawa S; Doi T; Miyanishi K; Takada K; Kukitsu T; Oku T; Masuko E; Nojiri S; Niitsu Y
    Hepatogastroenterology; 2004; 51(58):1135-9. PubMed ID: 15239261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of hepatocellular carcinoma by intraarterial injection of adriamycin/mitomycin C oil suspension (ADMOS) alone or combined with cis-diaminodichloroplatinum (CDDP).
    Inoue H; Miyazono N; Hori A; Miyake S; Satake M; Kanetsuki I; Nishida H; Ikeda K; Nakajo M
    Acta Radiol; 1993 Jul; 34(4):388-91. PubMed ID: 8391290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Repermeability of portal vein after intra-arterial lipiodol chemotherapy in patients with hepatocellular carcinoma. Report of 3 cases].
    Derhy S; Bessis L; Atallah R; Ajavon Y; Eisele G; Roche A
    Gastroenterol Clin Biol; 1990; 14(11):893-5. PubMed ID: 2177429
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemoembolization of hepatocellular carcinomas. A study of the biodistribution and pharmacokinetics of doxorubicin.
    Raoul JL; Heresbach D; Bretagne JF; Ferrer DB; Duvauferrier R; Bourguet P; Messner M; Gosselin M
    Cancer; 1992 Aug; 70(3):585-90. PubMed ID: 1320447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intraarterial injection therapy of CDDP-PC-lipiodol suspension for hepatoma].
    Aikawa H; Mori H; Hirao K; Ajimu A; Iwao M; Hayashi K; Hombo Z; Ogasawara M; Nakashima M; Ichikawa M
    Nihon Gan Chiryo Gakkai Shi; 1988 Jul; 23(7):1585-9. PubMed ID: 2846720
    [No Abstract]   [Full Text] [Related]  

  • 17. Adriamycin and methyl-CCNU combination therapy in hepatocellular carcinoma: clinical and pharmacokinetic aspects.
    Chlebowski RT; Chan KK; Tong MJ; Weiner JM; Ryden VM; Bateman JR
    Cancer; 1981 Sep; 48(5):1088-95. PubMed ID: 6268277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intraarterial Adriamycin for patients with hepatocellular carcinoma and metastatic liver carcinoma].
    Ueoka H; Kuroda S; Ohnoshi T; Kimura I; Numoto A; Hino I; Takahashi M; Tsuji M
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2579-84. PubMed ID: 6095763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacological and clinical studies on lipiodol emulsion for hepatocellular carcinoma].
    Kodama T; Arima K; Sakamoto H; Suga M; Yachi A
    Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2544-8. PubMed ID: 2843121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Enhanced effect of hepatic arterial infused anticancer drugs on rabbit VX-2 carcinoma by means of combination with Lipiodol. Adriamycin versus Lipiodol adriamycin sandwich method and adriamycin suspended in a Lipiodol].
    Hoshino M; Koyama Y; Sugano K; Kanno M; Satou N; Abe R
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2810-3. PubMed ID: 2551224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.